Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT01720186). This is a study registration, not published results. Lead sponsor: Institut Claudius Regaud. Recruitment status: TERMINATED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 46 participants (ACTUAL). Conditions: Non Small Cell Lung Cancer, Lung Nodule. Interventions: DEVICE: PET/CT 4D imaging in a synchronized mode centered on the thorax.. Primary outcome measures: Feasibility of the PET/CT synchronized exam with SPI device ("success" or "failure" ) , 2 years. Brief summary: This is a pilot study, single-center, prospective, open-label, to assess the acceptability and performance of the experimental medical device (SPI) used during an imaging examination (PET / CT 4D imaging in synchronized mode centered on the thorax). Each patient will be its own control, since the imaging examination will be synchronized simultaneously with the two systems: tested Medical Device (SPI) and reference Medical Device(RPM).